Enterprise Value

11.44B

Cash

637.6M

Avg Qtr Burn

N/A

Short % of Float

2.86%

Insider Ownership

9.76%

Institutional Own.

89.23%

Qtr Updated

03/31/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date